IL37244A - Labelled diagnostic compositions containing polysaccharides - Google Patents
Labelled diagnostic compositions containing polysaccharidesInfo
- Publication number
- IL37244A IL37244A IL37244A IL3724471A IL37244A IL 37244 A IL37244 A IL 37244A IL 37244 A IL37244 A IL 37244A IL 3724471 A IL3724471 A IL 3724471A IL 37244 A IL37244 A IL 37244A
- Authority
- IL
- Israel
- Prior art keywords
- labelling agent
- molecular weight
- groups per
- sulfated
- diagnostically effective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5270770A | 1970-07-06 | 1970-07-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL37244A0 IL37244A0 (en) | 1971-10-20 |
| IL37244A true IL37244A (en) | 1974-07-31 |
Family
ID=21979383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL37244A IL37244A (en) | 1970-07-06 | 1971-07-06 | Labelled diagnostic compositions containing polysaccharides |
Country Status (12)
| Country | Link |
|---|---|
| BE (1) | BE769554A (https=) |
| CA (1) | CA946741A (https=) |
| CH (1) | CH565559A5 (https=) |
| DE (1) | DE2133005A1 (https=) |
| ES (1) | ES392966A1 (https=) |
| FR (1) | FR2100869B1 (https=) |
| GB (1) | GB1355559A (https=) |
| IE (1) | IE35439B1 (https=) |
| IL (1) | IL37244A (https=) |
| NL (1) | NL7109318A (https=) |
| SE (1) | SE399821B (https=) |
| ZA (1) | ZA714438B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672334A (en) * | 1991-01-16 | 1997-09-30 | Access Pharmaceuticals, Inc. | Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans |
| US5312616A (en) * | 1993-03-11 | 1994-05-17 | Sterling Winthrop Inc. | Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract |
| US5310538A (en) * | 1993-03-11 | 1994-05-10 | Sterling Winthrop Inc. | Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE372421B (https=) * | 1968-04-01 | 1974-12-23 | Minnesota Mining & Mfg |
-
1971
- 1971-07-02 DE DE19712133005 patent/DE2133005A1/de active Pending
- 1971-07-05 GB GB3139671A patent/GB1355559A/en not_active Expired
- 1971-07-06 IE IE862/71A patent/IE35439B1/xx unknown
- 1971-07-06 IL IL37244A patent/IL37244A/en unknown
- 1971-07-06 BE BE769554A patent/BE769554A/xx unknown
- 1971-07-06 CA CA117,489A patent/CA946741A/en not_active Expired
- 1971-07-06 FR FR7124697A patent/FR2100869B1/fr not_active Expired
- 1971-07-06 NL NL7109318A patent/NL7109318A/xx unknown
- 1971-07-06 SE SE7108719A patent/SE399821B/xx unknown
- 1971-07-06 ZA ZA714438A patent/ZA714438B/xx unknown
- 1971-07-06 ES ES392966A patent/ES392966A1/es not_active Expired
- 1971-07-06 CH CH989571A patent/CH565559A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE399821B (sv) | 1978-03-06 |
| DE2133005A1 (de) | 1972-01-20 |
| ES392966A1 (es) | 1975-04-16 |
| IL37244A0 (en) | 1971-10-20 |
| BE769554A (fr) | 1972-01-06 |
| CA946741A (en) | 1974-05-07 |
| FR2100869B1 (https=) | 1974-09-06 |
| IE35439B1 (en) | 1976-02-18 |
| IE35439L (en) | 1972-01-06 |
| NL7109318A (https=) | 1972-01-10 |
| GB1355559A (en) | 1974-06-05 |
| CH565559A5 (https=) | 1975-08-29 |
| ZA714438B (en) | 1972-08-30 |
| FR2100869A1 (https=) | 1972-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3852413A (en) | Labelled sulfated amylopectins and method of determining abnormal gastrointestinal mucosa | |
| Misiewicz et al. | Effect of oral prostaglandin E1 on intestinal transit in man | |
| Padmanabhan et al. | Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CT | |
| Mojaverian et al. | Gastrointestinal transit of a solid indigestible capsule as measured by radiotelemetry and dual gamma scintigraphy | |
| Majd et al. | Hepatobiliary scintigraphy with 99mTc-PIPIDA in the evaluation of neonatal jaundice | |
| Bunker SR et al. | Scintigraphy of gastrointestinal hemorrhage: superiority of 99mTc red blood cells over 99mTc sulfur colloid | |
| Brunner et al. | Gastrointestinal transit and 5‐ASA release from a new mesalazine extended‐release formulation | |
| Merrick et al. | Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT) | |
| Collins et al. | Transcobalamin II receptor imaging via radiolabeled diethylene-triaminepentaacetate cobalamin analogs | |
| Wilson et al. | Assessment of disintegration and dissolution of dosage forms in vivo using gamma scintigraphy | |
| Dawson et al. | Detection of inflammatory bowel disease in adults and children: evaluation of a new isotopic technique. | |
| McLean et al. | Oral colon transit scintigraphy using indium-111 DTPA: variability in healthy subjects | |
| Dunson et al. | Preparation and comparison of technetium-99m diphosphonate, polyphosphate and pyrophosphate nuclear bone imaging radiopharmaceuticals | |
| EP0092993B1 (en) | Composition for investigating alimentary functions | |
| IL37244A (en) | Labelled diagnostic compositions containing polysaccharides | |
| Dunson et al. | 99mTc minicolloid for radionuclide lymphography | |
| MALMUD et al. | Quantitation of gastroesophageal reflux before and after therapy using the gastroesophageal scintiscan | |
| Marvola et al. | Neutron activation-based gamma scintigraphy in pharmacoscintigraphic evaluation of an Egalet® constant-release drug delivery system | |
| Huntter et al. | The gastric emptying of hard gelatin capsules | |
| Kaufman et al. | Effects of liquid versus solid diet on colonic transit in humans: evaluation by standard colonic transit scintigraphy | |
| Ercan et al. | 99mTc-labelled monodisperse latex particles coated with amino or carboxyl groups for studies of GI function | |
| Vaira et al. | Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases | |
| Smith et al. | The advantages of delayed imaging and radiographic correlation in scintigraphic localization of gastrointestinal bleeding. | |
| AU2001282575B8 (en) | Preparations for diagnosing extrapancreatic secretory function | |
| Charron et al. | 99 mTc antigranulocyte monoclonal antibody imaging for the detection and assessment of inflammatory bowel disease newly diagnosed by colonoscopy in children |